[ Price : $8.95]
FDA grants Incyte accelerated approval of its BLA for Zynyz (retifanlimab-dlwr) for treating adults with metastatic or recurrent l...[ Price : $8.95]
The Senate Homeland Security & Governmental Affairs majority staff issues a report recommending six things FDA, Congress, and othe...[ Price : $8.95]
Pharmaceutical Research and Manufacturers of America tells the White House Office of Science and Technology Policy its three sugge...[ Price : $8.95]
Roche and Eli Lilly collaborate to develop Roches Elecsys Amyloid Plasma Panel, a blood test designed for making earlier diagnoses...[ Price : $8.95]
The CBER FY 2022 biological product deviation reporting annual summary says there was a 3% increase in reports submitted over FY 2...[ Price : $8.95]
A new University of Colorado Boulder study points to the need for FDA to work harder to follow and consider further regulating soc...[ Price : $8.95]
FDA approves an expanded indication for Regeneron Pharmaceuticals Evkeeza (evinacumab-dgnb) as an adjunct to other lipid-lowering ...[ Price : $8.95]
Karuna Therapeutics plans a mid-year NDA for schizophrenia drug KarXT (xanomeline-trospium) after reporting positive topline resul...